Institut Claudius Regaud IUCT-ONCOPOLE
Toulouse, 31059, France
NCT Number: NCT03289286
This is a monocentric, prospective cohort study evaluating the feasibility of a perioperative e-follow-up protocol in patients with ambulatory surgery for breast cancer.
This protocol will be based on:
* A coordinated ambulatory follow-up performed by a dedicated nurse * An electronic follow-up tool used in pre- and post-surgery
Patients will be followed 8 days before the surgery until 30 days after the surgery of breast cancer.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Toulouse, 31059, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In pre- and post-surgery:
Time frame: 1.5 months by patient
Time frame: 1.5 months by patient
Satisfaction will be evaluated by questionnaire.
Time frame: 1.5 months by patient
Time frame: 1.5 months by patient
Time frame: 1.5 months by patient
Time frame: 1.5 months by patient
It will be defined as the sum of the time spent at different stages: initial training of patients, tracking of the connections to the tool, tracking of the alerts and telephone contacts.
Institut Claudius Regaud
Other
Acronym: PITCA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05181722
Breast Cancer, Breast Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT07760714
Breast Cancer, Breast Diseases
East Hanover, New Jersey, United States
View Trial DetailsNCT07764653
Breast Cancer, Breast Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT05562518
Breast Cancer, Breast Diseases
Ghent, Belgium
View Trial Details